• 16/11/2022

    Register for the online symposium ‘Use of digital tools in support of treatment of people with tuberculosis’

    On Wednesday, November 30, the online symposium ‘Use of digital tools in support of treatment of people with tuberculosis’ will…

    Lees meer
  • 01/11/2022

    Publication: Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients

    Christiaan Mulder, Senior Epidemiologist at KNCV Tuberculosis Foundation, was part of the research “Preventive Treatment for Household Contacts of…

    Lees meer
  • 27/10/2022

    A story from Mulanje district, Southern region, Malawi

    Linda Kabotolo is a 27-year-old woman with two children. She comes from Mabuka in Matekenya village in Mulanje district. Kabotolo…

    Lees meer
  • 11/10/2022

    KNCV Tuberculosis Foundation launches the People-Centered Framework (PCF) Knowledge Hub

    KNCV Tuberculosis Foundation (KNCV) today announced the launch of the People-Centered Framework (PCF) Knowledge Hub, an online…

    Lees meer
  • 22/09/2022

    The Netherlands contributes € 180 million to end tuberculosis, HIV and malaria

    The Netherlands is contributing €180 million to the worldwide fight against tuberculosis (TB), HIV/AIDS and malaria. Minister Liesje Schreinemacher of…

    Lees meer
  • 05/08/2022

    KNCV is excited to join the USAID-funded, Johns Hopkins Medicine-led SMART4TB project

    With an investment of $200 million from USAID, Johns Hopkins Medicine launches the Supporting, Mobilizing and Accelerating Research…

    Lees meer
  • 08/04/2022

    Webinar: What’s next for Global Health in the wake of the pandemic?

    The Clingendael Institute organizes a series of online events regarding the complexities around the future of…

    Lees meer
  • 24/03/2022

    New LIFT-TB website highlights efforts to transform TB therapy amidst resurgence during COVID-19 pandemic

    The world continues to battle against two pandemics: COVID-19 and tuberculosis (TB). TB had long been the deadliest infectious disease—until…

    Lees meer
  • 24/03/2022

    ASCENT project: invest in innovative digital tools to end TB

    The Unitaid-funded ASCENT project has entered its final year and is well on its way in showing the benefits…

    Lees meer
  • 24/03/2022

    TREATS releases final report

    The TREATS (Tuberculosis Reduction through Expanded Antiretroviral Treatment and Screening for Active TB) project has just released its…

    Lees meer
  • 24/03/2022

    IMPAACT4TB raises awareness and access to TB Preventative Treatment

    About a quarter of the world’s population is infected with Mycobacterium Tuberculosis and thus at risk of developing tuberculosis (TB)…

    Lees meer
  • 24/03/2022

    KardiaMobile for ECG monitoring: Innovative approach to help DR-TB patients in Kazakhstan

    KNCV is constantly looking for innovative approaches for patient-centered care. Patients with drug resistant tuberculosis (DR-TB) who receive treatment with…

    Lees meer
  • 04/03/2022

    Save the date: Wolfheze Workshops 2022

    Regaining lost ground: ending TB in Europe 16th WHO National TB Programme Managers’ Meeting and 20th Wolfheze Workshops…

    Lees meer
  • 28/02/2022

    New platform on digital adherence technologies for tuberculosis treatment

    As a part of the Global digital adherence technology (DAT) Task Force, KNCV Tuberculosis Foundation is pleased to announce the…

    Lees meer
  • 21/02/2022

    Dr. Bakyt Myrzaliev receives ‘Award for Partnership to End TB’

    Dr. Bakyt Myrzaliev, KNCV representative in Kyrgyzstan, has been awarded the ‘Award for Partnership to End TB’ by the…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.